论文部分内容阅读
目的观察优泌乐25治疗2型糖尿病的临床疗效。方法选择52例需胰岛素治疗的2型糖尿病患者,随机分为两组,A组为优泌乐25组,B组为优泌林70/30组,治疗12周。结果两组治疗后空腹血糖控制水平相似,A组餐后2h血糖控制优于B组,且HbA1c下降较B组明显,胰岛素用量少,低血糖发生率低。结论优泌乐25可以更加有效地控制餐后血糖,减少低血糖发生,安全性好。
Objective To observe the clinical efficacy of Uehara 25 in the treatment of type 2 diabetes mellitus. Methods Fifty-two patients with type 2 diabetes requiring insulin therapy were randomly divided into two groups. Group A was Gutiuxile and group B was Guorulin 70/30 for 12 weeks. Results The fasting blood glucose control was similar between the two groups. The postprandial blood glucose control in group A was better than that in group B, and the decrease of HbA1c was more obvious than that in group B, with less insulin and low hypoglycemia. Conclusion Youji 25 can more effectively control postprandial blood glucose, reduce hypoglycemia, good safety.